Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers studied older women with breast cancer to discover why some people are particularly susceptible to “chemo brain.”
Patients and providers must have the evidence that they need and deserve to inform effective medical care.
Turns out mutations in the TP53 gene are focused on so-called “hot spots” because specific carcinogens target those spots.
Cancer geneticists, epidemiologists and oncologists team up to use mutation rate to predict individual cancer risk.
The study used two FDA-approved drugs to the pre-leukemic cells while leaving healthy stem cells alone.
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer.
Though researchers knew that exosomes play important roles in cancer and in the immune system, only now are they learning the specifics.
The findings lay the groundwork for tests that can identify whether the disease is likely to progress rapidly.
“It stands to reason that we should develop treatments specifically for appendix cancer.”
A conversation with Dr. Charles Modlin of the Cleveland Clinic about the MENtion It survey
A common mutation makes mouse tumors more vulnerable to certain cancer drugs.
Researchers say it would be ideal to have future clinical trials in which tissue-based biomarker studies dictate treatment options.
Novel technique lets researchers control common cancer pathway in the lab with pulses of light.
Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease.
The researchers say their discovery suggests potential new targeted therapeutic strategies for the disease.
Some experts question why women who are fragile and advanced in years are screened for breast cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.